Calida Therapeutics is a seed startup based in France. 1 investor tracked. Status: dead.
Calida Therapeutics is a startup based in France. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Calida Therapeutics is a preclinical stage biotechnology company specialized in developing monoclonal antibodies to treat and prevent thrombo-inflammatory disorders by disrupting the molecular link between thrombosis and inflammation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.